StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

CTT Pharmaceutical's ebitda for the twelve months ending Dec 31, 2011 was -$757.94K. For fiscal 2011 it was -$757.94K.

Annual ebitda

PeriodPeriod endValueChange
FY2011Dec 31, 2011-$757.94K–
FY2010Dec 31, 2010-$2.00M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2011Dec 31, 2011-$186.89K–
Q3 FY2011Sep 30, 2011-$107.42K–
Q4 FY2010Dec 31, 2010-$564.55K–
Q3 FY2010Sep 30, 2010-$957.12K–
Q2 FY2010Jun 30, 2010-$361.12K–

More CTT Pharmaceutical figures

See a number that looks wrong?